AABB Smartbrief
- I cannot and will not cut my conscience to fit this year's fashions.
- Nearly 500K people could gain Medicaid coverage after election
- Learning extends beyond the 2018 AABB Annual Meeting
- Moderna seeks to raise $500M in IPO
- FDA grants emergency use authorization for Chembio's Ebola test
Blood Journal
- Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma
- Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable
- Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress
- Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis
- Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis